EXTENDICARE INC (EXE.CA) Fundamental Analysis & Valuation
TSX:EXE • CA30224T8639
26.22 CAD
-0.21 (-0.79%)
Last: Mar 3, 2026, 07:00 PM
This EXE.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Overall EXE gets a fundamental rating of 6 out of 10. We evaluated EXE against 13 industry peers in the Health Care Providers & Services industry. While EXE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. EXE has a decent growth rate and is not valued too expensively.
1. EXE.CA Profitability Analysis
1.1 Basic Checks
- EXE had positive earnings in the past year.
- In the past year EXE had a positive cash flow from operations.
- Each year in the past 5 years EXE has been profitable.
- In the past 5 years EXE always reported a positive cash flow from operatings.
1.2 Ratios
- EXE has a Return On Assets of 10.41%. This is amongst the best in the industry. EXE outperforms 92.31% of its industry peers.
- EXE's Return On Equity of 55.53% is amongst the best of the industry. EXE outperforms 92.31% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 18.54%, EXE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for EXE is above the industry average of 7.67%.
- The last Return On Invested Capital (18.54%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROIC | 18.54% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
- EXE has a better Profit Margin (5.72%) than 92.31% of its industry peers.
- In the last couple of years the Profit Margin of EXE has grown nicely.
- EXE's Operating Margin of 8.22% is fine compared to the rest of the industry. EXE outperforms 76.92% of its industry peers.
- In the last couple of years the Operating Margin of EXE has grown nicely.
- With a Gross Margin value of 14.15%, EXE is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of EXE has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. EXE.CA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EXE is creating value.
- Compared to 1 year ago, EXE has more shares outstanding
- EXE has less shares outstanding than it did 5 years ago.
- EXE has a better debt/assets ratio than last year.
2.2 Solvency
- EXE has an Altman-Z score of 3.82. This indicates that EXE is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.82, EXE belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
- EXE has a debt to FCF ratio of 3.39. This is a good value and a sign of high solvency as EXE would need 3.39 years to pay back of all of its debts.
- EXE has a Debt to FCF ratio of 3.39. This is in the better half of the industry: EXE outperforms 76.92% of its industry peers.
- EXE has a Debt/Equity ratio of 1.94. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.94, EXE is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Altman-Z | 3.82 |
ROIC/WACC2.49
WACC7.44%
2.3 Liquidity
- A Current Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
- The Current ratio of EXE (0.81) is comparable to the rest of the industry.
- A Quick Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
- EXE has a better Quick ratio (0.81) than 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 |
3. EXE.CA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 52.52% over the past year.
- EXE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.74% yearly.
- Looking at the last year, EXE shows a quite strong growth in Revenue. The Revenue has grown by 11.59% in the last year.
- The Revenue has been growing slightly by 5.31% on average over the past years.
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
3.2 Future
- EXE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.75% yearly.
- The Revenue is expected to grow by 10.83% on average over the next years. This is quite good.
EPS Next Y33.67%
EPS Next 2Y21.07%
EPS Next 3Y19.7%
EPS Next 5Y9.75%
Revenue Next Year15.21%
Revenue Next 2Y24.61%
Revenue Next 3Y17.83%
Revenue Next 5Y10.83%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. EXE.CA Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 25.21, the valuation of EXE can be described as expensive.
- 84.62% of the companies in the same industry are more expensive than EXE, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of EXE to the average of the S&P500 Index (26.83), we can say EXE is valued inline with the index average.
- EXE is valuated rather expensively with a Price/Forward Earnings ratio of 22.42.
- Based on the Price/Forward Earnings ratio, EXE is valued a bit cheaper than 76.92% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of EXE to the average of the S&P500 Index (24.95), we can say EXE is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.21 | ||
| Fwd PE | 22.42 |
4.2 Price Multiples
- 76.92% of the companies in the same industry are more expensive than EXE, based on the Enterprise Value to EBITDA ratio.
- EXE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EXE is cheaper than 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.84 | ||
| EV/EBITDA | 15.97 |
4.3 Compensation for Growth
- EXE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- EXE has an outstanding profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as EXE's earnings are expected to grow with 19.70% in the coming years.
PEG (NY)0.75
PEG (5Y)1.11
EPS Next 2Y21.07%
EPS Next 3Y19.7%
5. EXE.CA Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.09%, EXE has a reasonable but not impressive dividend return.
- EXE's Dividend Yield is a higher than the industry average which is at 1.39.
- Compared to an average S&P500 Dividend Yield of 1.82, EXE has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.09% |
5.2 History
- The dividend of EXE has a limited annual growth rate of 2.79%.
- EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
- EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
- EXE pays out 45.22% of its income as dividend. This is a bit on the high side, but may be sustainable.
- The dividend of EXE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP45.22%
EPS Next 2Y21.07%
EPS Next 3Y19.7%
EXE.CA Fundamentals: All Metrics, Ratios and Statistics
TSX:EXE (3/3/2026, 7:00:00 PM)
26.22
-0.21 (-0.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26 2026-02-26
Earnings (Next)05-04 2026-05-04
Inst Owners24.82%
Inst Owner ChangeN/A
Ins Owners0.96%
Ins Owner ChangeN/A
Market Cap2.48B
Revenue(TTM)1.59B
Net Income(TTM)91.00M
Analysts78
Price Target24.43 (-6.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.09% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP45.22%
Div Incr Years1
Div Non Decr Years3
Ex-Date02-27 2026-02-27 (0.042)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.07%
PT rev (3m)28.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)7.98%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)2.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.21 | ||
| Fwd PE | 22.42 | ||
| P/S | 1.56 | ||
| P/FCF | 24.84 | ||
| P/OCF | 16.21 | ||
| P/B | 15.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.97 |
EPS(TTM)1.04
EY3.97%
EPS(NY)1.17
Fwd EY4.46%
FCF(TTM)1.06
FCFY4.03%
OCF(TTM)1.62
OCFY6.17%
SpS16.83
BVpS1.74
TBVpS-0.37
PEG (NY)0.75
PEG (5Y)1.11
Graham Number6.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROCE | 24.53% | ||
| ROIC | 18.54% | ||
| ROICexc | 26.92% | ||
| ROICexgc | 58.63% | ||
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% | ||
| FCFM | 6.27% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexgc growth 3Y72.34%
ROICexgc growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Debt/EBITDA | 1.91 | ||
| Cap/Depr | 150.97% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | 9.89 | ||
| Cash Conversion | 92.12% | ||
| Profit Quality | 109.55% | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 3.82 |
F-Score6
WACC7.44%
ROIC/WACC2.49
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
EPS Next Y33.67%
EPS Next 2Y21.07%
EPS Next 3Y19.7%
EPS Next 5Y9.75%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
Revenue Next Year15.21%
Revenue Next 2Y24.61%
Revenue Next 3Y17.83%
Revenue Next 5Y10.83%
EBIT growth 1Y30.7%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year10.63%
EBIT Next 3Y17.06%
EBIT Next 5Y9.15%
FCF growth 1Y199.78%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y343.54%
OCF growth 3Y31.32%
OCF growth 5Y26.02%
EXTENDICARE INC / EXE.CA FAQ
What is the fundamental rating for EXE stock?
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.
What is the valuation status for EXE stock?
ChartMill assigns a valuation rating of 6 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.
What is the profitability of EXE stock?
EXTENDICARE INC (EXE.CA) has a profitability rating of 8 / 10.
Can you provide the expected EPS growth for EXE stock?
The Earnings per Share (EPS) of EXTENDICARE INC (EXE.CA) is expected to grow by 33.67% in the next year.
Is the dividend of EXTENDICARE INC sustainable?
The dividend rating of EXTENDICARE INC (EXE.CA) is 5 / 10 and the dividend payout ratio is 45.22%.